Related Experiment Videos
Predictive value of alexithymia: a prospective study in somatizing patients
Psychotherapy and Psychosomatics
|January 1, 1995
Summary
High alexithymia, a difficulty identifying emotions, predicts persistent somatoform disorders long-term. This finding was independent of other psychopathology measures in patients with somatoform and anxiety disorders.
Area of Science:
- Psychiatry
- Psychology
- Clinical Psychology
Background:
- Alexithymia is characterized by difficulty identifying and describing emotions.
- Somatoform disorders involve physical symptoms without a clear medical cause.
- Understanding predictors of long-term treatment outcomes is crucial for these conditions.
Purpose of the Study:
- To prospectively investigate alexithymia's role in predicting long-term treatment outcomes.
- To assess the predictive value of alexithymia in patients with somatoform and anxiety disorders.
Main Methods:
- Prospective study of 30 patients diagnosed with DSM-III-R somatoform or anxiety disorders.
- Diagnostic assessment using SCID interviews before inpatient treatment and 2 years post-discharge.
- Measurement of alexithymia using the Toronto Alexithymia Scale (TAS).
Main Results:
- Higher pretreatment alexithymia scores were observed in patients with persistent undifferentiated somatoform disorder at follow-up.
- Patients in remission or without prior somatoform criteria had lower alexithymia scores.
- Stepwise logistic regression identified high alexithymia as a significant predictor of persistent somatization.
Conclusions:
- High alexithymia is a significant predictor of persistent somatization in patients with somatoform disorders.
- This predictive relationship remained significant even when controlling for psychopathology, sociodemographics, and illness severity.
- Findings suggest alexithymia assessment may aid in predicting long-term outcomes for somatoform disorders.